MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Human intelectin-1 (ITLN1) genetic variation and intestinal expression

Author(s)
Nonnecke, Eric B; Castillo, Patricia A; Dugan, Amanda E; Almalki, Faisal; Underwood, Mark A; De La Motte, Carol A; Yuan, Weirong; Lu, Wuyuan; Shen, Bo; Johansson, Malin EV; Kiessling, Laura L; Hollox, Edward J; Lönnerdal, Bo; Bevins, Charles L; ... Show more Show less
Thumbnail
DownloadPublished version (1.598Mb)
Publisher with Creative Commons License

Publisher with Creative Commons License

Creative Commons Attribution

Terms of use
Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record
Abstract
Intelectins are ancient carbohydrate binding proteins, spanning chordate evolution and implicated in multiple human diseases. Previous GWAS have linked SNPs in ITLN1 (also known as omentin) with susceptibility to Crohn’s disease (CD); however, analysis of possible functional signifcance of SNPs at this locus is lacking. Using the Ensembl database, pairwise linkage disequilibrium (LD) analyses indicated that several disease-associated SNPs at the ITLN1 locus, including SNPs in CD244 and Ly9, were in LD. The alleles comprising the risk haplotype are the major alleles in European (67%), but minor alleles in African superpopulations. Neither ITLN1 mRNA nor protein abundance in intestinal tissue, which we confrm as goblet-cell derived, was altered in the CD samples overall nor when samples were analyzed according to genotype. Moreover, the missense variant V109D does not infuence ITLN1 glycan binding to the glycan β-D-galactofuranose or protein–protein oligomerization. Taken together, our data are an important step in defning the role(s) of the CD-risk haplotype by determining that risk is unlikely to be due to changes in ITLN1 carbohydrate recognition, protein oligomerization, or expression levels in intestinal mucosa. Our fndings suggest that the relationship between the genomic data and disease arises from changes in CD244 or Ly9 biology, diferences in ITLN1 expression in other tissues, or an alteration in ITLN1 interaction with other proteins.
Date issued
2021
URI
https://hdl.handle.net/1721.1/141094
Department
Massachusetts Institute of Technology. Department of Chemistry; Koch Institute for Integrative Cancer Research at MIT
Journal
Scientific Reports
Publisher
Springer Science and Business Media LLC
Citation
Nonnecke, Eric B, Castillo, Patricia A, Dugan, Amanda E, Almalki, Faisal, Underwood, Mark A et al. 2021. "Human intelectin-1 (ITLN1) genetic variation and intestinal expression." Scientific Reports, 11 (1).
Version: Final published version

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.